menu
    • menu

    Company profile for Cedilla Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We founded Cedilla at a time of fundamental and rapidly growing insight into the mechanisms underlying protein stability. Small molecules that degrade or stablize target proteins are precedented, but have been discovered serendipitously. Cedilla is taking an integrated approach to discover new drugs with this mode of action. Our present focus is to develop novel medicines in oncology, but this approach will also be applicable ...
    We founded Cedilla at a time of fundamental and rapidly growing insight into the mechanisms underlying protein stability. Small molecules that degrade or stablize target proteins are precedented, but have been discovered serendipitously. Cedilla is taking an integrated approach to discover new drugs with this mode of action. Our present focus is to develop novel medicines in oncology, but this approach will also be applicable to other fields, including central nervous system disorders and genetic diseases. Cedilla launched with $56.2 million in Series A funding from Third Rock Ventures.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Cedilla TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Cedilla Therapeutics 38 Sidney Street, 2nd Floor Cambridge, MA 02139
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.cedillatx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Bayer to acquire exclusive license from Cedilla Therapeutics
    Bayer to acquire exclusive license from Cedilla Therapeutics

    01 Jun 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230601005747/en

    BUSINESSWIRE
    01 Jun 2023
    Share Share
    Bayer inks Cedilla cancer deal to join pack chasing Pfizer
    Bayer inks Cedilla cancer deal to join pack chasing Pfizer

    01 Jun 2023

    // Nick Paul Taylor FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/bayer-inks-cedilla-cancer-deal-betting-take-tough-target-will-beat-pfizer-and-chasing-pack#:~:text=Bayer%20inks%20Cedilla%20cancer%20deal%2C%20betting%20take%20on%20tough%20target,Pfizer%20and%20the%20chasing%20pack&text=Bayer%20is%20joining%20Blueprint%20Medicines,to%20the%20more%20advanced%20rivals.

    Nick Paul Taylor FIERCE BIOTECH
    01 Jun 2023
    Share Share
    Third Rock shrinks another biotech as Cedilla restructures, CEO and CBO depart
    Third Rock shrinks another biotech as Cedilla restructures, CEO and CBO depart

    23 Feb 2023

    // Kyle LaHucik ENDPTS

    https://endpts.com/third-rock-shrinks-another-biotech-as-cedilla-restructures-ceo-and-cbo-depart/

    Kyle LaHucik ENDPTS
    23 Feb 2023
    Share Share
    Cedilla adds $25M to series B to test two cancer drugs in trials
    Cedilla adds $25M to series B to test two cancer drugs in trials

    26 Oct 2021

    // K. LaHucik FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/cedilla-tops-off-series-b-additional-25m-to-test-drugs-mesothelioma-certain-breast-cancers

    K. LaHucik FIERCEBIOTECH
    26 Oct 2021
    Share Share
    Cedilla Unveils Lead Programs for Conditional Inhibition of TEAD & CDK2
    Cedilla Unveils Lead Programs for Conditional Inhibition of TEAD & CDK2

    21 Oct 2021

    // BIOSPACE

    https://www.biospace.com/article/releases/cedilla-therapeutics-unveils-lead-programs-for-the-conditional-inhibition-of-tead-and-cdk2-two-high-value-and-historically-undruggable-cancer-drivers/?s=71

    BIOSPACE
    21 Oct 2021
    Share Share
    Cedilla and HitGen Announce Research Collaboration Focused on DNA-Encoded
    Cedilla and HitGen Announce Research Collaboration Focused on DNA-Encoded

    30 Nov 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20201130005084/en

    BUSINESSWIRE
    30 Nov 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search